Shuttle Pharmaceuticals Holdings, Inc.

US$5.58As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SHPHHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (89.72%)
Div yield —
ROE (90.05%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.01
PE TTM —
TSR TTM (81.20%)
Mkt cap US$26.61M
ROIC (59.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.37
(3.85%)
24.18%
Buy 9|2|5|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.07
0.07
0.08
5.13%
8.56%
11.19%
15.83%
Revenue$M
2.714
2.743
2.727
2.889
(1.04%)
0.99%
(2.37%)
4.90%
Peers (US$26.61M)
Cap (US$)
PE
26.95M
—
Capital
TTM
5Y
10Y
Leveragex
0.842
0.610
0.493
EBIT/Intx
0.352
0.940
0.685
Own earn%
49.29
(24.48)
(35.16)
Sh yield%
37.64
9.12
13.20
Owners
Insiders/Inst%
5.62
50.40
Short interest%
0.52
SBC / revenue%
2.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
1–7
$1 testx
—
Incr. ROIC%
15